New drug combo aims to shrink Hard-to-Treat tumours
NCT ID NCT06868199
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 34 times
Summary
This early-phase study tests a new drug called LM-168, alone or with another drug (toripalimab), in 87 adults with advanced solid tumours that have stopped responding to standard treatments. The goal is to check safety and find the best dose, and to see if the drugs can shrink tumours. This is not a cure, but aims to control the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOURS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Bayview Health-Investigational Drug Services
RECRUITINGPerth, Western Australia, 6009, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Beijing Cancer Hospital
NOT_YET_RECRUITINGBeijing, Beijing Municipality, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Cancer Care Wollongong Pty Limited
RECRUITINGWollongong, New South Wales, Australia
Contact Email: •••••@•••••
-
MUPharm Pty Limited trading as Macquarie University Hospital Parmarcy
RECRUITINGRyde, New South Wales, 2109, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Macquarie University
RECRUITINGRyde, New South Wales, 2109, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
One Clinical Reasearch
RECRUITINGPerth, Western Australia, 6009, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.